IFNG and cancer: When activated with IL-2, NK92 cells were found to have no/low cytotoxicity against NK sensitive cancer stem cells; however, they retained the ability to secrete high levels of regulatory cytokines IL-6 and IL-10 with no or slight secretion of IFN-γ and TNF-α.